# Genuine Research Center, Egypt clinical trials: 38 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 38 trials with Genuine Research Center, Egypt as lead sponsor, 0 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Genuine Research Center, Egypt: 38 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/genuine-research-center-egypt

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 38
- Recruiting or not yet: 0
- Read on: November 19, 2026

## Trials

The 25 newest of 38, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| May 30, 2023 | NCT05880056 | Study of Bisoprolol (Nerkardou - Nerhadou International) 5 and 10 mg Oral Dissolvable Film (ODF) Treatment in Egyptian Patients With... | Genuine Research Center, Egypt | Phase 4 | Unknown | Essential Hypertension | 406 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05880056) |
| May 25, 2023 | NCT05876585 | Clinical Trial to Investigate the Efficacy and Safety of Ondansetron (Danset - Adwia) Versus Placebo Plus the Standard of Care in the... | Genuine Research Center, Egypt | Phase 3 | Unknown | Gastroenteritis | 126 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05876585) |
| May 11, 2023 | NCT05855187 | Bioequivalence Study of Modafinil From Bravamax 200 mg Scored Tablets (Chemipharm Pharmaceutical Industries, Egypt) Versus Vigil 200 mg... | Genuine Research Center, Egypt | Phase 1 | Completed | Healthy | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05855187) |
| April 7, 2023 | NCT05804721 | Bioequivalence Study of Aripiprazole From Apipe 10 mg Orally Disintegrating Tablets (Man. by: P&C Labs (Pellets & CR Products), Egypt)... | Genuine Research Center, Egypt | Phase 1 | Completed | Healthy | 29 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05804721) |
| April 5, 2023 | NCT05798715 | Bioequivalence Study of of Metformin HCl From Gleptomet 50/1000 mg F.C.Tablets (EVA Pharma, Egypt) and Janumet 50/1000 mg F.C.Tablets... | Genuine Research Center, Egypt | Phase 1 | Completed | Healthy | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05798715) |
| March 14, 2023 | NCT05767632 | Bioequivalence Study of Solifenacin Succinate & Mirabegron From Mirfenacin MR 5/50 mg Extended Release Tablets (Hikma Pharma, Egypt) Versus... | Genuine Research Center, Egypt | Phase 1 | Completed | Healthy | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05767632) |
| August 8, 2022 | NCT05491330 | Bioequivalence Study of Nirmatrelvir & Ritonavir From Copaxid 150 +100 mg Tablets (Eva Pharma, Egypt) Versus Paxlovid 150 + 100 mg Film... | Genuine Research Center, Egypt | Phase 1 | Completed | Healthy | 28 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05491330) |
| November 26, 2021 | NCT05135793 | Bioequivalence Study of Vonoprazan From Topoprazan 20 mg Tablets (Hikma Pharma, Egypt) Versus Takecab 20 mg Tablets (Takeda Pharmaceutical... | Genuine Research Center, Egypt | Phase 1 | Completed | Healthy | 29 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05135793) |
| November 23, 2021 | NCT05132023 | Bioequivalence Study of Empagliflozin & Metformin HCL From Empagliform 12.5/1000 mg F.C.T (Hikma Pharma, Egypt) and Synjardy 12.5/1000 mg... | Genuine Research Center, Egypt | Phase 1 | Completed | Healthy | 26 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05132023) |
| September 9, 2021 | NCT05038969 | Bioequivalence Study of Esomeprazole From Stomopral 40 mg Capsules Contain Enteric Coated Pellets (Future Pharmaceuticals Industries... | Genuine Research Center, Egypt | Phase 1 | Completed | Healthy | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05038969) |
| August 16, 2021 | NCT05006768 | Bioequivalence Study of Baricitinib From Barcimiant 4 mg Film Coated Tablets (Horus Pharma, Egypt) and Olumiant 4 mg Film Coated Tablets... | Genuine Research Center, Egypt | Phase 1 | Completed | Healthy | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05006768) |
| April 22, 2021 | NCT04854538 | Bioequivalence Study of Budesonide From Ekmasonid 9 mg Extended Release FCT (Hikma Pharma, Egypt) Versus Uceris 9 mg Extended Release... | Genuine Research Center, Egypt | Phase 1 | Completed | Healthy | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04854538) |
| April 22, 2021 | NCT04854460 | Bioequivalence Study of Ivermectin From Revemact 6 mg Tablets (Man. by EVA Pharma for Horus for Pharmaceutical Industries, Egypt) and... | Genuine Research Center, Egypt | Phase 1 | Completed | Healthy | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04854460) |
| December 8, 2020 | NCT04657744 | Bioequivalence Study of Fingolimod From Sphingomod 0.5 mg Hard Gelatin Capsules (Hikma Pharma, Egypt) Versus Gilenya 0.5 mg Hard Capsules... | Genuine Research Center, Egypt | Phase 1 | Completed | Healthy | 34 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04657744) |
| October 27, 2020 | NCT04605107 | Biosimilarity Study of IM Injection of Human Chorionic Gonadotrophin After Parenteral Administration of Treatment A TEST Product Epifasi... | Genuine Research Center, Egypt | Phase 4 | Completed | Infertility, Female | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04605107) |
| July 31, 2020 | NCT04494191 | Bioequivalence Study of Flibanserin From AphroFemine 100 mg F.C.T (Bio Med for Pharmaceuticals Industries (BIOMED), Egypt) Versus Addyi 100... | Genuine Research Center, Egypt | Phase 1 | Completed | Healthy | 26 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04494191) |
| July 20, 2020 | NCT04478448 | Bioequivalence Study of Favipiravir From Flupirava 200 mg Tablet (European Egyptian Pharmaceutical Industries , Egypt) Versus Avigan 200 mg... | Genuine Research Center, Egypt | Phase 1 | Completed | Healthy | 26 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04478448) |
| July 20, 2020 | NCT04476966 | Bioequivalence Study of Mirabegron From Bladogra 25 mg Extended Release Tablets (Multi-Apex for Pharmaceutical Industries, Egypt) Versus... | Genuine Research Center, Egypt | Phase 1 | Completed | Healthy | 29 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04476966) |
| July 31, 2019 | NCT04039958 | A Study of Sofosbuvir and Ledipasvir From Soviredia 90/400 mg Tablets (Minapharm, Egypt) Versus Harvoni 90/400 mg Tablets (Gilead Sciences... | Genuine Research Center, Egypt | Phase 1 | Completed | Healthy | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04039958) |
| February 26, 2019 | NCT03855306 | A Bioequivalence Study of Glibenclamide From Glibesyn 5 mg Tablets (Medochemie LTD Cyprus) and Daonil 5 mg Tablets (Sanofi-Aventis Cyprus... | Genuine Research Center, Egypt | Phase 1 | Completed | Healthy | 27 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03855306) |
| March 6, 2017 | NCT03071380 | Bioequivalence Study of Rivaroxaban From Repatoxaban 10 mg Tablets (Horus for Pharmaceutical Industries, Egypt) and Xarelto® 10 mg Tablets... | Genuine Research Center, Egypt | Phase 1 | Completed | Healthy | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03071380) |
| February 23, 2017 | NCT03062423 | A Bio-equivalence Study of Sofosbuvir From Sofodelevier 400 mg Film Coated Tablets (Al-debeiky Pharma, Egypt) Versus Sovaldi 400 mg Tablets... | Genuine Research Center, Egypt | Phase 1 | Completed | Healthy | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03062423) |
| December 29, 2016 | NCT03005210 | A Study of Sofosbuvir and Ledipasvir From Magicbuvir Plus 90/400 mg Tablets (Magic Pharma, Egypt) Versus Harvoni 90/400 mg Tablets (Gilead... | Genuine Research Center, Egypt | Phase 1 | Completed | Healthy | 37 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03005210) |
| November 2, 2016 | NCT02953535 | A Bio-equivalence Study of Sofosbuvir From Magicbuvir 400 mg Film Coated Tablets ( Magic Pharma, Egypt) Versus Sovaldi 400 mg Tablets... | Genuine Research Center, Egypt | Phase 1 | Completed | Healthy | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02953535) |
| August 5, 2016 | NCT02857946 | Bioequivalence Study of Linagliptin From Prevaglip 5 mg Tablets(Eva Pharma, Egypt) and Trajenta 5 mg Tablets (Boehringer Ingelheim... | Genuine Research Center, Egypt | Phase 1 | Completed | Healthy | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02857946) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 35 |
| Phase 3 | 1 |
| Phase 4 | 2 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 36 |
| Unknown | 2 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Essential Hypertension | 1 |
| Infertility, Female | 1 |
| Gastroenteritis | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Cheesesteak restaurants in the United States](https://specstream.ai/data/businesses/cheesesteak-restaurants/united-states)
- [Wholesale florists in the United States](https://specstream.ai/data/businesses/wholesale-florists/united-states)
- [Publishers in the United States](https://specstream.ai/data/businesses/publishers/united-states)
- [Latin American restaurants in the United States](https://specstream.ai/data/businesses/latin-american-restaurants/united-states)
- [Engineering firms in the United States](https://specstream.ai/data/businesses/engineering-firms/united-states)
- [Beach resorts in the United States](https://specstream.ai/data/businesses/beach-resorts/united-states)
